Menu
Search Close

Investors

Advisors

Country of Incorporation :
UK

Main Country of Operation:
UK

Company registered address and number:
John Eccles House 
Robert Robinson Avenue
Oxford Science Park 
Oxford
OX4 4GP
Company registration number: 06564638(England and Wales)

Registrar:
SLC Registrars
Elder House
St George's Business Park
Weybridge
Surrey
KT13 0TS
Telephone +44 (0)1903 706 150 
Fax +44 (0)333 207 6354

Nominated advisor and Broker:
Panmure Gordon and Co
One New Change
London
EC4M 9AF

Auditor:
Champion Accountants LLP
2nd Floor
Refuge House
33-37 Watergate Row
Chester
CH1 2LE

Solicitor:
Cooley (UK) LLP
Dashwood
69 Old Broad Street
London
EC2M 1QS

Webcasts, Interviews and Media Coverage

Scancell on verge of recruiting patients with advanced melanoma for UK clinical trials

The immunotherapy specialist gave an update on progress for a “busy and productive” half-year.

Mon, 01 Jul 2019 11:19:00

Vulpes Life Sciences Fund's Martin Diggle discusses Scancell investment

Martin Diggle, co-founder of Vulpes Investment Management which manages the Vulpes Life Sciences Fund, discusses their recent investment into Scancell Holdings PLC (LON:SCLP).

After buying 77.56mln new shares at a price of 5p per share, which was a slight discount to the 5.35p closing price the previous day, the Vulpes Life Sciences Fund will have a 16.67% stake in the company.

Fri, 21 Jun 2019 08:21:00

Scancell welcomes strategic new investor Vulpes Life Sciences Fund

Scancell Holdings PLC (LON:SCLP) CEO Cliff Holloway caught up with Proactive London's Andrew Scott following the announcement they'd raised £3.88mln via a placing with a single new investor to help fund the progression of its lead cancer asset into clinical trials.

The Vulpes Life Sciences Fund will now have a 16.67% stake in the company when the shares are issued next Monday.

Thu, 13 Jun 2019 09:53:00